PATH Live Forums: New tools in the treatment of P. vivax malaria

New tools for improving detection and treatment of Plasmodium vivax (P. vivax) malaria, like single-dose tafenoquine and point-of-care diagnostics, are expanding access to radical cure treatment options—but turning innovation into impact requires more than approval. This session brings together country experiences and global insights on the policies, tools, and operational systems needed to ensure people can reach the care they need. We’ll explore the practical steps that scale approval of new innovations into real-world access and the progress being made in the fight against P. vivax malaria.

Webinar supported in part by an unrestricted educational grant from GSK Global Health.

Please note that simultaneous Portuguese interpretation will be available.